Published in J Virol on February 01, 1998
Interaction of bovine papillomavirus E2 protein with Brd4 stabilizes its association with chromatin. J Virol (2005) 1.87
Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function. J Virol (2006) 1.81
The linking regions of EBNA1 are essential for its support of replication and transcription. Mol Cell Biol (1999) 1.80
Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells. J Virol (2000) 1.71
The papillomavirus E2 proteins. Virology (2013) 1.30
AMF-1/Gps2 binds p300 and enhances its interaction with papillomavirus E2 proteins. J Virol (2000) 1.30
Analysis of chromatin attachment and partitioning functions of bovine papillomavirus type 1 E2 protein. J Virol (2004) 1.29
Brd4-independent transcriptional repression function of the papillomavirus e2 proteins. J Virol (2007) 1.19
Direct interaction between nucleosome assembly protein 1 and the papillomavirus E2 proteins involved in activation of transcription. Mol Cell Biol (2004) 1.14
Cooperative activation of human papillomavirus type 8 gene expression by the E2 protein and the cellular coactivator p300. J Virol (2002) 1.10
The Papillomavirus E2 protein binds to and synergizes with C/EBP factors involved in keratinocyte differentiation. J Virol (2003) 1.01
Tax1BP1 interacts with papillomavirus E2 and regulates E2-dependent transcription and stability. J Virol (2008) 0.97
Small molecule inhibitors of human papillomavirus protein - protein interactions. Open Virol J (2011) 0.97
Effect of bovine papillomavirus E2 protein-specific monoclonal antibodies on papillomavirus DNA replication. J Virol (1999) 0.97
Interaction of papillomavirus E2 protein with the Brm chromatin remodeling complex leads to enhanced transcriptional activation. J Virol (2006) 0.93
Tumor suppressor or oncogene? A critical role of the human papillomavirus (HPV) E2 protein in cervical cancer progression. Am J Cancer Res (2011) 0.91
Induction of the bovine papillomavirus origin "onion skin"-type DNA replication at high E1 protein concentrations in vivo. J Virol (2002) 0.90
Modification of papillomavirus E2 proteins by the small ubiquitin-like modifier family members (SUMOs). Virology (2008) 0.89
Mapping the sequences that mediate interaction of the equine herpesvirus 1 immediate-early protein and human TFIIB. J Virol (2001) 0.88
Acetylation of conserved lysines in bovine papillomavirus E2 by p300. J Virol (2012) 0.85
NRIP, a novel calmodulin binding protein, activates calcineurin to dephosphorylate human papillomavirus E2 protein. J Virol (2011) 0.82
Phosphorylation of HPV-16 E2 at serine 243 enables binding to Brd4 and mitotic chromosomes. PLoS One (2014) 0.79
Phosphorylation of the bovine papillomavirus E2 protein on tyrosine regulates its transcription and replication functions. J Virol (2016) 0.75
High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol (1987) 43.61
Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID. Nature (1990) 7.11
Characterization of SAP-1, a protein recruited by serum response factor to the c-fos serum response element. Cell (1992) 7.07
Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA. Nature (1987) 5.61
Genetic isolation of ADA2: a potential transcriptional adaptor required for function of certain acidic activation domains. Cell (1992) 5.14
Binding of general transcription factor TFIIB to an acidic activating region. Nature (1991) 4.71
Drosophila TAFII40 interacts with both a VP16 activation domain and the basal transcription factor TFIIB. Cell (1993) 4.57
Crystal structure at 1.7 A of the bovine papillomavirus-1 E2 DNA-binding domain bound to its DNA target. Nature (1992) 4.12
Three functional classes of transcriptional activation domain. Mol Cell Biol (1996) 3.62
Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol Cell Biol (1994) 3.46
Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription. Cell (1991) 3.46
E2 polypeptides encoded by bovine papillomavirus type 1 form dimers through the common carboxyl-terminal domain: transactivation is mediated by the conserved amino-terminal domain. Proc Natl Acad Sci U S A (1989) 3.18
Eukaryotic activators function during multiple steps of preinitiation complex assembly. Nature (1993) 3.16
Transcriptional elongation by RNA polymerase II is stimulated by transactivators. Cell (1994) 3.15
Structural and mutational analysis of E2 trans-activating proteins of papillomaviruses reveals three distinct functional domains. EMBO J (1988) 3.01
Interaction between an acidic activator and transcription factor TFIIB is required for transcriptional activation. Nature (1993) 2.88
Multiple functional domains of human transcription factor IIB: distinct interactions with two general transcription factors and RNA polymerase II. Genes Dev (1993) 2.87
Activator-induced conformational change in general transcription factor TFIIB. Nature (1994) 1.97
Expression and purification of general transcription factors by FLAG epitope-tagging and peptide elution. Pept Res (1993) 1.80
Sequence-specific and general transcriptional activation by the bovine papillomavirus-1 E2 trans-activator require an N-terminal amphipathic helix-containing E2 domain. EMBO J (1988) 1.79
Interaction between a transcriptional activator and transcription factor IIB in vivo. Nature (1993) 1.66
The transcriptional repressor even-skipped interacts directly with TATA-binding protein. Mol Cell Biol (1995) 1.59
Reconstitution of human TFIIA activity from recombinant polypeptides: a role in TFIID-mediated transcription. Genes Dev (1994) 1.53
The bovine papillomavirus 1 E2 protein contains two activation domains: one that interacts with TBP and another that functions after TBP binding. EMBO J (1995) 1.50
Amino acids necessary for DNA contact and dimerization imply novel motifs in the papillomavirus E2 trans-activator. Genes Dev (1992) 1.49
Bovine papillomavirus type 1 E2 transcriptional regulators directly bind two cellular transcription factors, TFIID and TFIIB. J Virol (1995) 1.48
Genetic analysis of the activation domain of bovine papillomavirus protein E2: its role in transcription and replication. J Virol (1996) 1.44
Functional interactions between papillomavirus E1 and E2 proteins. J Virol (1997) 1.42
Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription. Proc Natl Acad Sci U S A (1995) 1.33
Transcriptional and replicational activation functions in the bovine papillomavirus type 1 E2 protein are encoded by different structural determinants. J Virol (1996) 1.33
Mapping and characterization of the interaction domains of human papillomavirus type 16 E1 and E2 proteins. J Virol (1997) 1.32
Amino-terminal domains of the bovine papillomavirus type 1 E1 and E2 proteins participate in complex formation. J Virol (1995) 1.31
Separation of the transcriptional activation and replication functions of the bovine papillomavirus-1 E2 protein. EMBO J (1992) 1.31
The E2 transcriptional repressor can compensate for Sp1 activation of the human papillomavirus type 18 early promoter. J Virol (1994) 1.28
Functional interaction of a novel cellular protein with the papillomavirus E2 transactivation domain. Mol Cell Biol (1997) 1.24
A 10-amino-acid sequence in the N-terminal A/B domain of thyroid hormone receptor alpha is essential for transcriptional activation and interaction with the general transcription factor TFIIB. Mol Cell Biol (1995) 1.21
The bovine papillomavirus type 1 E2 transactivator and repressor proteins use different nuclear localization signals. J Virol (1996) 1.20
Transcriptional activation domain of the herpesvirus protein VP16 becomes conformationally constrained upon interaction with basal transcription factors. J Biol Chem (1996) 1.19
Genetic analysis of the bovine papillomavirus E2 transcriptional activation domain. Virology (1996) 1.15
Transcriptional activation function is not required for stimulation of DNA replication by bovine papillomavirus type 1 E2. J Virol (1996) 1.14
The transactivation and DNA binding domains of the BPV-1 E2 protein have different roles in cooperative origin binding with the E1 protein. Virology (1996) 1.13
The acidic activation domain of the Epstein-Barr virus transcription factor R interacts in vitro with both TBP and TFIIB and is cell-specifically potentiated by a proline-rich region. Gene Expr (1993) 1.12
A direct interaction between a glutamine-rich activator and the N terminus of TFIIB can mediate transcriptional activation in vivo. Mol Cell Biol (1995) 1.09
A highly conserved domain of RNA polymerase II shares a functional element with acidic activation domains of upstream transcription factors. Mol Cell Biol (1994) 1.07
Characterization of the interaction between the acidic activation domain of VP16 and the RNA polymerase II initiation factor TFIIB. Nucleic Acids Res (1996) 0.98
The N-terminal domain of transcription factor IIB is required for direct interaction with the vitamin D receptor and participates in vitamin D-mediated transcription. Mol Endocrinol (1997) 0.85
Accessibility of epitopes on human transcription factor IIB in the native protein and in a complex with DNA. J Biol Chem (1995) 0.81
A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci U S A (1999) 7.60
Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA. Nature (1987) 5.61
A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet (1999) 5.09
Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. Science (1990) 4.92
The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet (1997) 4.86
SMN oligomerization defect correlates with spinal muscular atrophy severity. Nat Genet (1998) 3.51
An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum Mol Genet (2000) 3.41
Identification of the protein encoded by the E6 transforming gene of bovine papillomavirus. Science (1985) 3.21
Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines. EMBO J (1987) 2.84
Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). Proc Natl Acad Sci U S A (2000) 2.72
The specific DNA recognition sequence of the bovine papillomavirus E2 protein is an E2-dependent enhancer. EMBO J (1988) 2.66
Bovine papilloma virus-transformed cells contain multiple E2 proteins. Proc Natl Acad Sci U S A (1988) 2.29
Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science (1995) 2.20
Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells. J Virol (1999) 2.09
Light-mediated control of translational initiation of ribulose-1, 5-bisphosphate carboxylase in amaranth cotyledons. Plant Cell (1990) 1.86
Identification of bovine papillomavirus E1 mutants with increased transforming and transcriptional activity. J Virol (1989) 1.64
Amino acids necessary for DNA contact and dimerization imply novel motifs in the papillomavirus E2 trans-activator. Genes Dev (1992) 1.49
Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6-immortalized human mammary epithelial cells. EMBO J (1993) 1.49
Proteins encoded by the bovine papillomavirus E1 open reading frame: expression in heterologous systems and in virally transformed cells. J Virol (1990) 1.49
Identification of an alpha helical motif sufficient for association with papillomavirus E6. J Biol Chem (1998) 1.45
The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells. Oncogene (2009) 1.45
An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA. Gene Ther (2001) 1.37
The domain encoded by exon 2 of the survival motor neuron protein mediates nucleic acid binding. Hum Mol Genet (1998) 1.35
Cooperative binding of the E2 protein of bovine papillomavirus to adjacent E2-responsive sequences. J Virol (1991) 1.32
AMF-1/Gps2 binds p300 and enhances its interaction with papillomavirus E2 proteins. J Virol (2000) 1.30
Mechanism of action of the papillomavirus E2 repressor: repression in the absence of DNA binding. J Virol (1992) 1.29
Transcriptional activation by the papillomavirus E6 zinc finger oncoprotein. EMBO J (1990) 1.27
Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells. J Virol (1996) 1.24
Functional interaction of a novel cellular protein with the papillomavirus E2 transactivation domain. Mol Cell Biol (1997) 1.24
Crystal structure of the E2 DNA-binding domain from human papillomavirus type 16: implications for its DNA binding-site selection mechanism. J Mol Biol (1998) 1.23
Identification of survival motor neuron as a transcriptional activator-binding protein. Hum Mol Genet (1999) 1.22
X-linked inheritance of epidermodysplasia verruciformis. Genetic and virologic studies of a kindred. Arch Dermatol (1985) 1.21
The exon 2b region of the spinal muscular atrophy protein, SMN, is involved in self-association and SIP1 binding. Hum Mol Genet (2000) 1.21
Trans activation by the bovine papillomavirus E2 protein in Saccharomyces cerevisiae. J Virol (1989) 1.18
Genetic analysis of the bovine papillomavirus E2 transcriptional activation domain. Virology (1996) 1.15
Transcriptional activation function is not required for stimulation of DNA replication by bovine papillomavirus type 1 E2. J Virol (1996) 1.14
Mutational analysis of bovine papillomavirus E6 gene. J Virol (1989) 1.05
AMF1 (GPS2) modulates p53 transactivation. Mol Cell Biol (2001) 1.02
Solution structure determination and mutational analysis of the papillomavirus E6 interacting peptide of E6AP. Biochemistry (2001) 1.01
hAda3 regulates p14ARF-induced p53 acetylation and senescence. Oncogene (2007) 0.99
The domain of p53 required for binding HPV 16 E6 is separable from the degradation domain. Oncogene (1995) 0.98
Specific inhibition of a human papillomavirus E2 trans-activator by intracellular delivery of its repressor. DNA Cell Biol (1994) 0.98
Cellular transformation by papillomavirus oncoproteins. Biochim Biophys Acta (1993) 0.96
Human papillomavirus type 16 E6-enhanced susceptibility of L929 cells to tumor necrosis factor alpha correlates with increased accumulation of reactive oxygen species. J Biol Chem (1999) 0.94
Regulation of murine survival motor neuron (Smn) protein levels by modifying Smn exon 7 splicing. Hum Mol Genet (2001) 0.94
A novel method for selective isotope labeling of bacterially expressed proteins. J Biomol NMR (1995) 0.92
Structural correlates for enhanced stability in the E2 DNA-binding domain from bovine papillomavirus. Biochemistry (1999) 0.90
The tryptophan bridge is a critical feature of the papillomavirus E2 DNA binding domain. Virology (1993) 0.88
The BPV-1 E2 DNA-contact helix cysteine is required for transcriptional activation but not replication in mammalian cells. Virology (1996) 0.88
Mutational analysis of transcriptional activation by the bovine papillomavirus type 1 E6. Virology (1997) 0.86
Response of warts in epidermodysplasia verruciformis to treatment with systemic and intralesional alpha interferon. J Am Acad Dermatol (1984) 0.84
Papillomaviruses and interferon. Ciba Found Symp (1986) 0.83
Human papillomavirus DNA sequences in cell lines derived from head and neck squamous cell carcinomas. Otolaryngol Head Neck Surg (1991) 0.82
Increased ouabain-sensitive glycolysis of lymphocytes treated with phytohemagglutinin: relationship to potassium transport. J Cell Physiol (1978) 0.81
Antigen presentation and T-cell activation in epidermodysplasia verruciformis. J Invest Dermatol (1990) 0.81
Two distinct regions of the BPV1 E1 replication protein interact with the activation domain of E2. Virus Res (1999) 0.80
1H, 15N, and 13C NMR resonance assignments for the DNA-binding domain of the BPV-1 E2 protein. J Biomol NMR (1998) 0.80
Sequences flanking the core DNA-binding domain of bovine papillomavirus type 1 E2 contribute to DNA-binding function. J Virol (1997) 0.80
Papillomavirus-associated inductions of cellular proteins in mouse C127 cells: correlation with the presence of open reading frame E2. Virology (1989) 0.79
Polyomavirus large T can support DNA replication in human cells. Virology (1998) 0.78
The bovine papillomavirus type 1 E6 oncoprotein sensitizes cells to tumor necrosis factor alpha-induced apoptosis. Oncogene (1999) 0.77
Rb-independent induction of apoptosis by bovine papillomavirus type 1 E7 in response to tumor necrosis factor alpha. J Biol Chem (2000) 0.77
Isolation, sequence analysis and characterization of a cDNA encoding human chaperonin 10. Biochim Biophys Acta (1994) 0.76
Assignment of the gene for ERC-55 (RCN2) to human chromosome band 15q22.33-->q24.1 by in situ hybridization. Cytogenet Cell Genet (1997) 0.75
Tumor viruses, oncogenes, and human cancer. J Am Acad Dermatol (1984) 0.75
UV-B-energy distribution in phototherapy equipment. Arch Dermatol (1984) 0.75